FRAMEWORK AGREEMENT FOR THE AWARD OF A BIENNIAL SUPPLY UNDER DISTRIBUTION, DIVIDED INTO 2 LOTS, OF THE BIOLOGICAL DRUG DENOSUMAB REQUIRED BY THE HEALTH AND HOSPITAL AUTHORITIES OF THE SICILY REGION

This tender, awarded to ACCORD HEALTHCARE ITALIA SRL, establishes a framework agreement for the biennial supply of Denosumab, a biological drug, for healthcare and hospital authorities within the Sicily Region. The agreement is divided into two lots, with Lot 1 valued at EUR 8,612,946.85 and Lot 2 at EUR 3,024,025.83, for a total estimated value of EUR 11,636,972.68. The procurement procedure was open. Denosumab is a medication used to treat various bone-related conditions, including osteoporosis and bone metastases. This framework agreement will ensure a consistent and efficient supply of this critical medication to healthcare providers across Sicily, facilitating patient treatment and care. The contracting authority is the REGIONE SICILIANA. The award value for the contract was EUR 3,928,928.00.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 11.6 million.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.